listing tomorrow, page-2

See newswire from Zephyr - looks like they left out the artimist details - another 40m euro on top of what is mentioned.
Are they finally getting their act together?


HC Berlin plans stock market debut

Posted on Tuesday, 21 Oct 2008 16:43

HC Berlin Pharma, a German start-up pharmaceutical company, intends to list shares on the Frankfurt Stock Exchange in an initial public offering (IPO).

The listing should take place before the end of the week, HC Berlin said in a note to the bourse.

It is hoping to pique investor interest against weak markets with the promise of “immense revenues”.

The Berlin-based healthcare company, established in May 2007, has developed new ways of administering drugs that avoid the need for injections.

It expects high market demand, and recently invested in a new production facility in the Golm Science Park, where it hopes to begin production by the end of next year.

HC Berlin has developed new ways of administering active agents that have already been tested, with malaria and nicotine addiction its key areas of expertise.

Its main product is ArTiMist, a spray delivered under the tongue to treat malaria in infants and children.

NiCoSorb is its nicotine replacement product and has already caught the eye of drugstore chains in Europe.

HC Berlin has secured a contract with Australia’s Eastland Medial Systems that will see NiCoSorb distributed in overseas markets such as China, where the group expects to generate between EUR 70 million and EUR 75 million in sales next year.

The group also supplies sterile wrapping for products used in human and veterinary healthcare practice, generating revenue of around EUR 7.50 million from the segment.

HC Berlin moved from sterile packing into tamper evident and child-resistant wrapping, and expects to receive EUR 1.5 million in royalties next year from these operations.

© Zephus Ltd